Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation

BACKGROUND: Evidence and guidelines for Non-vitamin K antagonist oral anticoagulants (NOACs) use when prescribing concurrent rifampin for tuberculosis treatment in patients with non-valvular atrial fibrillation (NVAF) are limited. METHODS: Using the Korean National Health Insurance Service database...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Ki Won, Choi, Jin Hee, Lee, Soo Yong, Lee, Sang Hyun, Chon, Min Ku, Lee, Jungkuk, Kim, Hasung, Kim, Yong-Giun, Choi, Hyung Oh, Kim, Jeong Su, Park, Yong-Hyun, Kim, June Hong, Chun, Kook Jin, Nam, Gi-Byoung, Choi, Kee-Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074893/
https://www.ncbi.nlm.nih.gov/pubmed/37016321
http://dx.doi.org/10.1186/s12872-023-03212-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074893/
https://www.ncbi.nlm.nih.gov/pubmed/37016321
http://dx.doi.org/10.1186/s12872-023-03212-z

Ejemplares similares